PATENT CLAIM ANALYSIS

Application Number: 16023496
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["436", "086000"]

Abstract:
The invention pertains to diagnosis and treatment of ovarian cancer (OC), cervical cancer (CC), or colorectal cancer (CRC). One embodiment of the invention provides a method of identifying OC, CC, or CRC based on the level of RHAMM in the urine of a subject. Another embodiment of the invention provides a method of identifying OC based on the level of RHAMM in the urine and CA 125  in the blood of a subject. The invention also pertains to monitoring the efficacy of a treatment of OC, CC, or CRC based on the level of RHAMM protein in the urine and/or the level of CA 125  in the blood. Another embodiment of the invention provides devices and reagents to assay RHAMM in a urine sample and optionally, assay CA 125  in a blood sample.

Claim (Index 2):
The method of  claim 1 , wherein the reference value for the level of RHAMM:\n i) indicates the absence of OC, CC, or CRC and is between 0 to 15 pg/ml of urine, ii) indicates the presence of OC is between about 100 pg/ml to about 120 pg/ml of urine, iii) indicates the presence of CC or CRC and is between 60 pg/ml to about 100 pg/ml of urine.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 94.0
- Lexical Diversity: 3.14583
- Patent Class: 436.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11704408', '12066564', '11866475', '15577631', '11037889']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.716282270222836
- 35 USC 102 Novelty (BERT): 0.4922236016856005
- Combined Prediction Score: 0.6938764033691125
- Mean Citation Score: 207.41876
- Max Citation Score: 242.74283
- Similarity Product: 163.70426748015464

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test